DNA methylation at enhancers identifies distinct breast cancer lineages

Archive ouverte

Fleischer, Thomas | Tekpli, Xavier | Mathelier, Anthony | Wang, Shixiong | Nebdal, Daniel | Dhakal, Hari, P | Sahlberg, Kristine, Kleivi | Schlichting, Ellen | Sauer, Torill | Geisler, Jürgen | Hofvind, Solveig | Bathen, Tone, F | Engebraaten, Olav | Garred, Øystein | Geitvik, Gry, Aarum | Langerød, Anita | Kåresen, Rolf | Mælandsmo, Gunhild, Mari | Russnes, Hege, G | Sørlie, Therese | Lingjærde, Ole, Christian | Skjerven, Helle, Kristine | Park, Daehoon | Fritzman, Britt | Børresen-Dale, Anne-Lise | Borgen, Elin | Naume, Bjørn | Eskeland, Ragnhild | Frigessi, Arnoldo | Tost, Jörg | Hurtado, Antoni | Kristensen, Vessela, N

Edité par CCSD ; Nature Publishing Group -

International audience. Breast cancers exhibit genome-wide aberrant DNA methylation patterns. To investigate how these affect the transcriptome and which changes are linked to transformation or progression, we apply genome-wide expression–methylation quantitative trait loci (emQTL) analysis between DNA methylation and gene expression. On a whole genome scale, in cis and in trans , DNA methylation and gene expression have remarkably and reproducibly conserved patterns of association in three breast cancer cohorts ( n = 104, n = 253 and n = 277). The expression–methylation quantitative trait loci associations form two main clusters; one relates to tumor infiltrating immune cell signatures and the other to estrogen receptor signaling. In the estrogen related cluster, using ChromHMM segmentation and transcription factor chromatin immunoprecipitation sequencing data, we identify transcriptional networks regulated in a cell lineage-specific manner by DNA methylation at enhancers. These networks are strongly dominated by ERα, FOXA1 or GATA3 and their targets were functionally validated using knockdown by small interfering RNA or GRO-seq analysis after transcriptional stimulation with estrogen.

Suggestions

Du même auteur

Contrasting DCIS and invasive breast cancer by subtype suggests basal-like DCIS as distinct lesions

Archive ouverte | Bergholtz, Helga | CCSD

International audience. Ductal carcinoma in situ (DCIS) is a non-invasive type of breast cancer with highly variable potential of becoming invasive and affecting mortality. Currently, many patients with DCIS are ove...

Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk

Archive ouverte | Liu, Jingjing | CCSD

International audience. In breast cancer, high levels of homeobox protein Hox-B13 (HOXB13) have been associated with disease progression of ER-positive breast cancer patients and resistance to tamoxifen treatment. S...

Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

Archive ouverte | Michailidou, Kyriaki | CCSD

International audience. Genome-wide association studies (GWAS) and large-scale replication studies have identified common variants in 79 loci associated with breast cancer, explaining ∼14% of the familial risk of th...

Chargement des enrichissements...